Cho Pharma Inc.

4 clinical trials · Sponsor

Record	Firm	Date
Study of CHO-A04 in Advanced Solid Tumors (NCT07049458)	Cho Pharma Inc.	2025-12-01
An Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of a Bivalent Klebsiella Pneumoniae Vaccine (CHO-V08) in Healthy Adults (NCT07016152)	Cho Pharma Inc.	2025-06-26
A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma (NCT05950165)	Cho Pharma Inc.	2020-01-15
A Phase I Study of Intravenous CHO-H01 in Patients With Refractory or Relapsed Follicular Lymphoma (NCT03221348)	Cho Pharma Inc.	2018-03-01

Every clearance here is in the API, with alerts when new ones post.